Literature DB >> 26132522

Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application.

Valentina Sepe1, Eleonora Distrutti2, Vittorio Limongelli1,3, Stefano Fiorucci4, Angela Zampella1.   

Abstract

Bile acids (BAs) are experiencing a new life. Next to their ancestral roles in lipid digestion and solubilization, BAs are today recognized signaling molecules involved in many physiological functions. These signaling pathways involve the activation of metabolic nuclear receptors, mainly the BA sensor FXR, and the dedicated membrane G protein-coupled receptor, GPBAR1 (TGR5). As a consequence, the discovery of GPBAR1/FXR selective or dual modulators represents an important answer to the urgent demand of new pharmacological opportunity for several human diseases including dyslipidemia, cholestasis, nonalcoholic steatohepatitis, Type 2 diabetes and inflammation. Targeted oriented discovery of natural compounds and medicinal chemistry manipulation have allowed the development of promising drug candidates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26132522     DOI: 10.4155/fmc.15.54

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  7 in total

1.  Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations.

Authors:  Edithe Selwa; Eddy Elisée; Agustin Zavala; Bogdan I Iorga
Journal:  J Comput Aided Mol Des       Date:  2017-09-02       Impact factor: 3.686

2.  Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases.

Authors:  Carmen Festa; Simona De Marino; Adriana Carino; Valentina Sepe; Silvia Marchianò; Sabrina Cipriani; Francesco S Di Leva; Vittorio Limongelli; Maria C Monti; Angela Capolupo; Eleonora Distrutti; Stefano Fiorucci; Angela Zampella
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

3.  Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations.

Authors:  Federica Moraca; Jussara Amato; Francesco Ortuso; Anna Artese; Bruno Pagano; Ettore Novellino; Stefano Alcaro; Michele Parrinello; Vittorio Limongelli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-23       Impact factor: 11.205

Review 4.  Gut microbiota is a potential goalkeeper of dyslipidemia.

Authors:  Lirong Lei; Ning Zhao; Lei Zhang; Jiamei Chen; Xiaomin Liu; Shenghua Piao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

5.  Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands.

Authors:  Claudia Finamore; Carmen Festa; Barbara Renga; Valentina Sepe; Adriana Carino; Dario Masullo; Michele Biagioli; Silvia Marchianò; Angela Capolupo; Maria Chiara Monti; Stefano Fiorucci; Angela Zampella
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

6.  Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists.

Authors:  Valentina Sepe; Carmen Festa; Barbara Renga; Adriana Carino; Sabrina Cipriani; Claudia Finamore; Dario Masullo; Federica Del Gaudio; Maria Chiara Monti; Stefano Fiorucci; Angela Zampella
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

7.  Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain.

Authors:  Adriana Carino; Federica Moraca; Bianca Fiorillo; Silvia Marchianò; Valentina Sepe; Michele Biagioli; Claudia Finamore; Silvia Bozza; Daniela Francisci; Eleonora Distrutti; Bruno Catalanotti; Angela Zampella; Stefano Fiorucci
Journal:  Front Chem       Date:  2020-10-23       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.